Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Clin Microbiol Infect Dis ; 43(6): 1193-1203, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38536524

RESUMO

To assess clinical impact and perform cost-consequence analysis of the broadest multiplex PCR panels available for the rapid diagnosis of bloodstream infections (BSI). Single-center, randomized controlled trial conducted from June 2019 to February 2021 at a French University hospital with an institutional antimicrobial stewardship program. Primary endpoint was the percentage of patients with optimized antimicrobial treatment 12 h after transmission of positivity and Gram stain results from the first positive BC. This percentage was significantly higher in the multiplex PCR (mPCR) group (90/105 = 85.7% %, CI95% [77.5 ; 91.8] vs. 68/107 = 63.6%, CI95% [53.7 ; 72.6]; p < 10- 3) at interim analysis, resulting in the early termination of the study after the inclusion of 309 patients. For patients not optimized at baseline, the median time to obtain an optimized therapy was much shorter in the mPCR group than in the control group (6.9 h, IQR [2.9; 17.8] vs. 26.4 h, IQR [3.4; 47.5]; p = 0.001). Early optimization of antibiotic therapy resulted in a non-statistically significant decrease in mortality from 12.4 to 8.8% (p = 0.306), with a trend towards a shorter median length of stay (18 vs. 20 days; p = 0.064) and a non-significant reduction in the average cost per patient of €3,065 (p = 0.15). mPCR identified all the bacteria present in 88% of the samples. Despite its higher laboratory cost, the use of multiplex PCR for BSI diagnosis leads to early-optimised therapy, seems cost-effective and could reduce mortality and length of stay. Their impact could probably be improved if implemented 24/7.


Assuntos
Bacteriemia , Hemocultura , Reação em Cadeia da Polimerase Multiplex , Humanos , Masculino , Feminino , Reação em Cadeia da Polimerase Multiplex/métodos , Reação em Cadeia da Polimerase Multiplex/economia , Hemocultura/métodos , Pessoa de Meia-Idade , Idoso , Bacteriemia/diagnóstico , Bacteriemia/microbiologia , Bacteriemia/tratamento farmacológico , Análise Custo-Benefício , França , Antibacterianos/uso terapêutico , Gestão de Antimicrobianos , Sepse/diagnóstico , Sepse/microbiologia , Sepse/tratamento farmacológico , Idoso de 80 Anos ou mais , Técnicas de Diagnóstico Molecular/economia , Técnicas de Diagnóstico Molecular/métodos , Bactérias/isolamento & purificação , Bactérias/genética , Bactérias/classificação
2.
J Eur Acad Dermatol Venereol ; 16(4): 401-4, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12224703

RESUMO

Mycosis fungoides (MF) may present with atypical clinical manifestations. Usually it mimics various chronic dermatoses, with the appearance of ulcers during the tumour stage. Infrequently, cutaneous ulcers are the main or initial sign of lymphoma. We report the case of a man who presented multiple skin lesions that clinically appeared to be pyoderma gangrenosum (PG). However, histological and immunohistochemical examination revealed MF. This case illustrates that PG-like ulcers maybe atypical cutaneous manifestations of MF and exceptionally the presenting sign of this disease.


Assuntos
Micose Fungoide/patologia , Pioderma Gangrenoso/patologia , Úlcera Cutânea/patologia , Biópsia por Agulha , Terapia Combinada , Diagnóstico Diferencial , Evolução Fatal , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Micose Fungoide/diagnóstico , Micose Fungoide/terapia , Pioderma Gangrenoso/diagnóstico , Pioderma Gangrenoso/terapia , Índice de Gravidade de Doença , Úlcera Cutânea/diagnóstico , Úlcera Cutânea/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...